DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN: 6,753 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
6,753
Total FAERS Reports
66 (1.0%)
Deaths Reported
237
Hospitalizations
6,753
As Primary/Secondary Suspect
25
Life-Threatening
23
Disabilities
First Report: 1118 · Latest Report: 20250824
What Are the Most Common DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN Side Effects?
#1 Most Reported
Drug ineffective
1,155 reports (17.1%)
#2 Most Reported
Dizziness
759 reports (11.2%)
#3 Most Reported
Diarrhoea
570 reports (8.4%)
All DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 1,155 | 17.1% | 0 | 25 |
| Dizziness | 759 | 11.2% | 0 | 16 |
| Diarrhoea | 570 | 8.4% | 0 | 11 |
| Accidental overdose | 515 | 7.6% | 2 | 6 |
| Nausea | 408 | 6.0% | 0 | 20 |
| Overdose | 377 | 5.6% | 0 | 11 |
| Product use in unapproved indication | 356 | 5.3% | 0 | 8 |
| Somnolence | 304 | 4.5% | 1 | 6 |
| Insomnia | 259 | 3.8% | 0 | 8 |
| Feeling abnormal | 246 | 3.6% | 0 | 7 |
| Drug effective for unapproved indication | 242 | 3.6% | 0 | 0 |
| Wrong technique in product usage process | 238 | 3.5% | 0 | 3 |
| Incorrect product administration duration | 236 | 3.5% | 0 | 1 |
| Expired product administered | 222 | 3.3% | 0 | 6 |
| Vomiting | 220 | 3.3% | 0 | 17 |
| Headache | 215 | 3.2% | 0 | 11 |
| Dyspnoea | 168 | 2.5% | 0 | 13 |
| Fatigue | 160 | 2.4% | 0 | 8 |
| Inappropriate schedule of product administration | 159 | 2.4% | 0 | 1 |
| Cough | 149 | 2.2% | 0 | 17 |
Who Reports DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN Side Effects? Age & Gender Data
Gender: 65.5% female, 34.5% male. Average age: 61.7 years. Most reports from: US. View detailed demographics →
Is DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 0 |
| 2008 | 1 | 0 | 0 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 0 |
| 2011 | 5 | 0 | 1 |
| 2012 | 4 | 1 | 1 |
| 2013 | 9 | 2 | 4 |
| 2014 | 68 | 3 | 6 |
| 2015 | 325 | 2 | 21 |
| 2016 | 398 | 5 | 27 |
| 2017 | 481 | 0 | 23 |
| 2018 | 482 | 14 | 17 |
| 2019 | 458 | 0 | 15 |
| 2020 | 426 | 2 | 7 |
| 2021 | 210 | 1 | 7 |
| 2022 | 311 | 0 | 5 |
| 2023 | 311 | 1 | 7 |
| 2024 | 299 | 1 | 5 |
| 2025 | 104 | 0 | 6 |
What Is DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 3,451 |
| Cough | 1,472 |
| Nasopharyngitis | 500 |
| Respiratory tract congestion | 443 |
| Productive cough | 294 |
| Nasal congestion | 138 |
| Hypersensitivity | 108 |
| Covid-19 | 93 |
| Secretion discharge | 89 |
| Pulmonary congestion | 84 |
DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN vs Alternatives: Which Is Safer?
DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN vs DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE
DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN vs DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE
DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN vs DEXTROMETHORPHAN\GUAIFENESIN
DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN vs DEXTROSE
DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN vs DEXTROSE\DEXTROSE
DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN vs DEXTROSE\DEXTROSE\DOBUTAMINE\DOBUTAMINE
DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN vs DEXTROSE\HEPARIN
DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN vs DEXTROSE\LIDOCAINE
DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN vs DEXTROSE\SODIUM
DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN vs DIACETYLMORPHINE
Official FDA Label for DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN
Official prescribing information from the FDA-approved drug label.